Mergers and Acquisition News Surge SYSW


SYSWIN Inc. (Syswin) is a primary real estate service provider in China. The Company primarily provides real estate sales agency services to property developers relating to new residential properties, and its net revenue derived from sales agency services represented 97.1% of its total net revenue during the year ended December 31, 2009. It also provides real estate consultancy services, which include project consultancy services offered to developer clients and primary land development consultancy and agency services provided to primary land developers. As of December 31, 2009, the Company had operations in 17 cities throughout China. It conducts its primary real estate services business through Syswin Xing Ye and its subsidiaries. Syswin provide primary real estate services in China to

property and land developers with a focus on residential properties. The Company operates in two business segments: real estate sales agency services and real estate consultancy services.
SYSWIN Inc. Ameri (NYSE:SYSW) is very active today and traded between $1.76 - 1.89 with total traded volume of 21211 shares. At a current price of 1.87, SYSW is +0.27 - +16.87% from the previous close of $1.60. Moreover, At Current Market Price, SYSW is in distance of +35.54% from its 50-day Moving Average price of $1.3797 and +47.01% from its 200-day Moving Average price of $1.272.





SYSWIN Inc. (NYSE: SYSW) 18.1% HIGHER; announced that its Board of Directors has received a preliminary non-binding proposal letter dated September 7, 2012 from Mr. Liangsheng Chen ("Mr. Chen"), Chief Executive Officer, President and a director of the Company, to acquire all of the outstanding shares of the Company not currently owned by him and his affiliates in a going private transaction for US$0.50 per ordinary share and US$2.00 per American Depositary Share ("ADS", each ADS representing 4 ordinary shares) in cash. The chief executive of Syswin Inc. (SYSW, $1.86, +$0.26, +16.25%) has offered to take the Chinese real estate company private in a cash deal valuing it at about $97 million. Mr. Liangsheng Chen, who owns just under 60% of Syswin and is also its president and a director, has offered to acquire the rest of the company that isn't already owned by him for 50 cents an ordinary share and $2 an American depository share, with each ADS representing four ordinary shares. The offer is a 25% premium to the company's closing price Thursday.

Blue Chip Stock That Will Be Different from Others


Cell Therapeutics, Inc. (CTI) develops, acquires and commercializes treatments for cancer. The Company’s research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. As of December 31, 2011, CTI focused its efforts on Pixuvri (pixantrone dimaleate) (Pixuvri), OPAXIO (paclitaxel poliglumex) (OPAXIO), tosedostat, brostallicin and bisplatinates. As of December 31, 2011, it developed Pixuvri, an anthracycline derivative for the treatment of hematologic malignancies and solid tumors.
Cell Therapeutics (NCM:CTIC) is +0.53 - +29.61% from the previous close of $1.79. It traded between $1.85 - 2.40 with total traded volume of 2157745 shares. Keep a close eye on CTIC, as the stock has been showing unusual moves over the past weeks. At Current market price, CTIC has recovered +31.07% from its 52-week Low of 1.77 and has Pulled back -71.88% from its 52-week high of 8.25.




This report is essential reading for any serious investor, providing comprehensive financial information on a company's performance, position and cash flows over the past 3 years, includinginterim data. This information, extracted from reported financial statements, forms the building blocks for any analysis undertaken by investment professionals. - Key Stats and Ratios including; Valuation Ratios (e.g. Price/Earnings), Per Share Data (e.g. EPS), Profitability Ratios (e.g. Gross Margin), Management Effectiveness (e.g. Return on Equity), Financial Strength (e.g. Quick Ratio) and Dividend Information (e.g. Dividend Yield). - 3 years of history are available for most ratios (see above). - Share performance data and 12 month chart - Profit & Loss Account (3 years) - Balance sheet (3 years) - Cash Flow Statement (3 years) - Educational content: Definitions of ratios and guidance on using the data - Graphical analysis: All the key data in the report is charted. Reuters Investment Profile reports are now available for over 25,000 companies globally.Every report is updated weekly to ensure that the information remains current.